https://www.selleckchem.com/products/h-151.html
5% 5-year success rate is still of benefit due to a long-term response that may, in fact, be preferred in patients who refuse or cannot undergo surgery. Researchers have studied many non-FDA approved uses for imiquimod, including but not limited to its use to treat recurrent herpes simplex virus infection, squamous cell carcinoma in situ, and melanoma in situ.Aseptic meningitis is a term used to define inflammation of the brain meninges due to various etiologies with negative cerebrospinal fluid (CSF) bacterial cultures. It is one of the
Like
Comment
Share
